Plasminogen activator inhibitor-1 (PAI-1) modifies the formation of aggressive fibromatosis (desmoid tumor). (Q38331352)

2 September 2017

Plasminogen activator inhibitor-1 (PAI-1) modifies the formation of aggressive fibromatosis (desmoid tumor). (English)

1 reference

2 September 2017

1 reference

aggressive fibromatosis

1 reference

Catherine Fen Li

1

1 reference

2 September 2017

Christopher Kandel

2

1 reference

2 September 2017

Frank Baliko

3

1 reference

2 September 2017

Puviindran Nadesan

4

1 reference

2 September 2017

Nils Brünner

5

1 reference

2 September 2017

Benjamin A Alman

6

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

2 September 2017

1 reference

2 September 2017

24

1 reference

2 September 2017

9

1 reference

2 September 2017

1615-1624

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1208193

2 September 2017

0 references

cites work

Aggressive fibromatosis (desmoid tumor) is a monoclonal disorder.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

The urokinase-type plasminogen activator system in cancer metastasis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

Plasminogen-activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

beta-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

Autocrine regulation of human preadipocyte migration by plasminogen activator inhibitor-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

Fibromatoses in childhood: the desmoid/fibromatosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

Modulation of glioma cell invasion and motility by adenoviral gene transfer of PAI-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

Identification of FAP locus genes from chromosome 5q21

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

Matrix metalloproteinase activity modulates tumor size, cell motility, and cell invasiveness in murine aggressive fibromatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

Differential regulation of plasminogen activator and inhibitor gene transcription by the tumor suppressor p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

Plasminogen activator inhibitor 1 may promote tumour growth through inhibition of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

Suppressor of fused negatively regulates beta-catenin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

Mechanism and function of signal transduction by the Wnt/beta-catenin and Wnt/Ca2+ pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

Inhibitory role of plasminogen activator inhibitor-1 in invasion and proliferation of HLE hepatocellular carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

The androgen receptor can promote beta-catenin nuclear translocation independently of adenomatous polyposis coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

Liganded androgen receptor interaction with beta-catenin: nuclear co-localization and modulation of transcriptional activity in neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

Cyclooxygenase-two (COX-2) modulates proliferation in aggressive fibromatosis (desmoid tumor).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

Role of plasminogen activator-plasmin system in tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

Complex regulation of plasminogen activator inhibitor type-1 (PAI-1) gene expression by serum and substrate adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

Familial infiltrative fibromatosis (desmoid tumours) (MIM135290) caused by a recurrent 3' APC gene mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

Apc1638N: a mouse model for familial adenomatous polyposis-associated desmoid tumors and cutaneous cysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

Tcf-3 expression and beta-catenin mediated transcriptional activation in aggressive fibromatosis (desmoid tumour).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

Genetic deletion of receptor for hyaluronan-mediated motility (Rhamm) attenuates the formation of aggressive fibromatosis (desmoid tumor).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

The genetic background modifies the spontaneous and X-ray-induced tumor spectrum in the Apc1638N mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

Urokinase-type plasminogen activator and its receptor in colorectal cancer: independent prognostic factors of metastasis and cancer-specific survival and potential therapeutic targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

Cell cycle-dependent fluctuation of urokinase-type plasminogen activator, its receptor, and inhibitors in cultured bovine mammary epithelial and myoepithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

Metastasis of transgenic breast cancer in plasminogen activator inhibitor-1 gene-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

7 January 2021

Prognostic significance of PAI-1 and uPA in cytosolic extracts obtained from node-positive breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

7 January 2021

Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

7 January 2021

Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

7 January 2021

Immunocytochemical analysis of chromaffin cell proliferation in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208193

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1208193

1 reference

Dimensions Publication ID

2 September 2017

0 references

1 reference